Review




Structured Review

Tosoh Corporation tosoh variant mode
Tosoh Variant Mode, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pm42122023-201-11-11?v=Tosoh+Corporation
Average 86 stars, based on 1 article reviews
tosoh variant mode - by Bioz Stars, 2026-08
86/100 stars

Images



Similar Products

86
Tosoh Corporation tosoh variant mode
Tosoh Variant Mode, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pm42122023-201-11-11?v=Tosoh+Corporation
Average 86 stars, based on 1 article reviews
tosoh variant mode - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
Tosoh Corporation high-performance liquid chromatography using variant assay tosoh hlc-723 g7 variant mode
High Performance Liquid Chromatography Using Variant Assay Tosoh Hlc 723 G7 Variant Mode, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pmc06369878-58-10-12?v=Tosoh+Corporation
Average 90 stars, based on 1 article reviews
high-performance liquid chromatography using variant assay tosoh hlc-723 g7 variant mode - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Tosoh Corporation hemoglobin a1c tosoh g8 variant mode ion-exchange hplc method
OGTT Experimental Subjects: Descriptive
Hemoglobin A1c Tosoh G8 Variant Mode Ion Exchange Hplc Method, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pmc06169468-79-12-17?v=Tosoh+Corporation
Average 90 stars, based on 1 article reviews
hemoglobin a1c tosoh g8 variant mode ion-exchange hplc method - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Tosoh Corporation hemoglobin s results obtained with tosoh g8 in variant hba1c mode
Comparison between TOSOH G8 in <t> variant HbA1c mode, </t> Minicap FP system, and sickle solubility test
Hemoglobin S Results Obtained With Tosoh G8 In Variant Hba1c Mode, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pmc06817183-52-9-6?v=Tosoh+Corporation
Average 90 stars, based on 1 article reviews
hemoglobin s results obtained with tosoh g8 in variant hba1c mode - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Tosoh Corporation ion- exchange highperformance liquid chromatography method tosoh hlc-723g7hba1c variant mode
Comparison between TOSOH G8 in <t> variant HbA1c mode, </t> Minicap FP system, and sickle solubility test
Ion Exchange Highperformance Liquid Chromatography Method Tosoh Hlc 723g7hba1c Variant Mode, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pm28525822-66-5-11?v=Tosoh+Corporation
Average 90 stars, based on 1 article reviews
ion- exchange highperformance liquid chromatography method tosoh hlc-723g7hba1c variant mode - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Tosoh Corporation ion exchange, high performance, liquid chromatography analyser tosoh g7 a1c variant mode
Comparison between TOSOH G8 in <t> variant HbA1c mode, </t> Minicap FP system, and sickle solubility test
Ion Exchange, High Performance, Liquid Chromatography Analyser Tosoh G7 A1c Variant Mode, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pmc05286783-89-7-19?v=Tosoh+Corporation
Average 90 stars, based on 1 article reviews
ion exchange, high performance, liquid chromatography analyser tosoh g7 a1c variant mode - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Tosoh Corporation variant analysis mode of the tosoh automated glycohemoglobin analyzer hlc-723g8
Comparison between TOSOH G8 in <t> variant HbA1c mode, </t> Minicap FP system, and sickle solubility test
Variant Analysis Mode Of The Tosoh Automated Glycohemoglobin Analyzer Hlc 723g8, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pmc04247629-120-17-22?v=Tosoh+Corporation
Average 90 stars, based on 1 article reviews
variant analysis mode of the tosoh automated glycohemoglobin analyzer hlc-723g8 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Tosoh Corporation ionexchange hplc method tosoh hlc-723 g8 variant analysis mode
Comparison between TOSOH G8 in <t> variant HbA1c mode, </t> Minicap FP system, and sickle solubility test
Ionexchange Hplc Method Tosoh Hlc 723 G8 Variant Analysis Mode, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tosoh+variant+mode/pm24190149-20-30-33?v=Tosoh+Corporation
Average 90 stars, based on 1 article reviews
ionexchange hplc method tosoh hlc-723 g8 variant analysis mode - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


OGTT Experimental Subjects: Descriptive

Journal: Journal of the Endocrine Society

Article Title: Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women

doi: 10.1210/js.2018-00151

Figure Lengend Snippet: OGTT Experimental Subjects: Descriptive

Article Snippet: Serum was analyzed at the University of Missouri Diabetes Diagnostic Laboratory for hemoglobin A1c (HbA1c) (using the Tosoh G8 variant mode ion-exchange HPLC method; Tosoh Biosciences, San Francisco, CA).

Techniques:

OGTT study insulinogenic index and its relationship to HbA1c by subject. Panels A and B plot the insulinogenic index, an indicator of first-phase insulin release, which is calculated as Δ insulin from 0 to 30 minutes)/( Δ glucose from 0 to 30 minutes) ( Δ I 0-30 / Δ G 0-30 ). Panels C and D plot the equivalent index using C-peptide ( Δ CP 0-30 / Δ G 0-30 ). Panels A and C show two versions of the insulinogenic index, Δ I 0-30 / Δ G 0-30 and Δ CP 0-30 / Δ G 0-30 , by session (control, BPA). Panels B and D show the percentage change in outcomes between the BPA and control sessions, plotted against HbA1c, where the percentage change in the insulinogenic index or the C-peptide equivalent was calculated as the percentage change in outcome (% Δ X) between BPA and control sessions = 100% × (X BPA – X control )/X control . HbA1c was measured from the baseline blood draw of each subject’s first visit. A linear regression line is included in the scatterplots with shaded 95% CI. The correlations of these variables with HbA1c are (B) Δ I 0-30 / Δ G 0-30 Spearman = 0.92, P = 0.0014 and (D) Δ CP 0-30 / Δ G 0-30 Pearson = 0.97, P = 0.0001. Points are labeled with the subject IDs, which correspond to the rank ordering of their HbA1c (M1 to M8 = low to high). Shapiro-Wilk normality test was used to select Pearson or Spearman correlations, using P value cutoff of >0.3 as “normal.”

Journal: Journal of the Endocrine Society

Article Title: Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women

doi: 10.1210/js.2018-00151

Figure Lengend Snippet: OGTT study insulinogenic index and its relationship to HbA1c by subject. Panels A and B plot the insulinogenic index, an indicator of first-phase insulin release, which is calculated as Δ insulin from 0 to 30 minutes)/( Δ glucose from 0 to 30 minutes) ( Δ I 0-30 / Δ G 0-30 ). Panels C and D plot the equivalent index using C-peptide ( Δ CP 0-30 / Δ G 0-30 ). Panels A and C show two versions of the insulinogenic index, Δ I 0-30 / Δ G 0-30 and Δ CP 0-30 / Δ G 0-30 , by session (control, BPA). Panels B and D show the percentage change in outcomes between the BPA and control sessions, plotted against HbA1c, where the percentage change in the insulinogenic index or the C-peptide equivalent was calculated as the percentage change in outcome (% Δ X) between BPA and control sessions = 100% × (X BPA – X control )/X control . HbA1c was measured from the baseline blood draw of each subject’s first visit. A linear regression line is included in the scatterplots with shaded 95% CI. The correlations of these variables with HbA1c are (B) Δ I 0-30 / Δ G 0-30 Spearman = 0.92, P = 0.0014 and (D) Δ CP 0-30 / Δ G 0-30 Pearson = 0.97, P = 0.0001. Points are labeled with the subject IDs, which correspond to the rank ordering of their HbA1c (M1 to M8 = low to high). Shapiro-Wilk normality test was used to select Pearson or Spearman correlations, using P value cutoff of >0.3 as “normal.”

Article Snippet: Serum was analyzed at the University of Missouri Diabetes Diagnostic Laboratory for hemoglobin A1c (HbA1c) (using the Tosoh G8 variant mode ion-exchange HPLC method; Tosoh Biosciences, San Francisco, CA).

Techniques: Control, Labeling

OGTT Experimental Subjects: BPA Exposure and Outcome Variables

Journal: Journal of the Endocrine Society

Article Title: Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women

doi: 10.1210/js.2018-00151

Figure Lengend Snippet: OGTT Experimental Subjects: BPA Exposure and Outcome Variables

Article Snippet: Serum was analyzed at the University of Missouri Diabetes Diagnostic Laboratory for hemoglobin A1c (HbA1c) (using the Tosoh G8 variant mode ion-exchange HPLC method; Tosoh Biosciences, San Francisco, CA).

Techniques: Control

HG Clamp Subjects: Descriptive

Journal: Journal of the Endocrine Society

Article Title: Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women

doi: 10.1210/js.2018-00151

Figure Lengend Snippet: HG Clamp Subjects: Descriptive

Article Snippet: Serum was analyzed at the University of Missouri Diabetes Diagnostic Laboratory for hemoglobin A1c (HbA1c) (using the Tosoh G8 variant mode ion-exchange HPLC method; Tosoh Biosciences, San Francisco, CA).

Techniques:

HG Clamp Subjects: BPA Exposure and Outcome Variables

Journal: Journal of the Endocrine Society

Article Title: Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women

doi: 10.1210/js.2018-00151

Figure Lengend Snippet: HG Clamp Subjects: BPA Exposure and Outcome Variables

Article Snippet: Serum was analyzed at the University of Missouri Diabetes Diagnostic Laboratory for hemoglobin A1c (HbA1c) (using the Tosoh G8 variant mode ion-exchange HPLC method; Tosoh Biosciences, San Francisco, CA).

Techniques: Control

HG clamp study change in insulin release measures between control and BPA sessions. Percentage change in outcome (% Δ X) between BPA and control sessions = 100% × (X BPA – X control )/X control . Points are labeled with the subject IDs, which correspond to the rank ordering of their HbA1c levels (M1 to M5, F1 to F3 = low to high). The Shapiro-Wilk normality test was used to select parametric vs nonparametric tests and correlations, using P value >0.3 as “normal.” (A) Late-phase insulin = mean insulin from clamp time 90 to 120 minutes minus fasting insulin . Six of 8 values for % Δ in late-phase insulin are less than zero ( t test, P = 0.042). (B) C-peptide Cmax. Seven of 8 values for % Δ C-peptide Cmax are less than zero ( t test, P = 0.046). (C) C-peptide AUC from 70 to 120 minutes. Seven of 8 values for % Δ C-peptide AUC 70-120 min are less than zero ( t test, P = 0.06). (D) The Spearman correlation of % Δ C-peptide AUC 70-120 min with HbA1c was –0.66, P = 0.076.

Journal: Journal of the Endocrine Society

Article Title: Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women

doi: 10.1210/js.2018-00151

Figure Lengend Snippet: HG clamp study change in insulin release measures between control and BPA sessions. Percentage change in outcome (% Δ X) between BPA and control sessions = 100% × (X BPA – X control )/X control . Points are labeled with the subject IDs, which correspond to the rank ordering of their HbA1c levels (M1 to M5, F1 to F3 = low to high). The Shapiro-Wilk normality test was used to select parametric vs nonparametric tests and correlations, using P value >0.3 as “normal.” (A) Late-phase insulin = mean insulin from clamp time 90 to 120 minutes minus fasting insulin . Six of 8 values for % Δ in late-phase insulin are less than zero ( t test, P = 0.042). (B) C-peptide Cmax. Seven of 8 values for % Δ C-peptide Cmax are less than zero ( t test, P = 0.046). (C) C-peptide AUC from 70 to 120 minutes. Seven of 8 values for % Δ C-peptide AUC 70-120 min are less than zero ( t test, P = 0.06). (D) The Spearman correlation of % Δ C-peptide AUC 70-120 min with HbA1c was –0.66, P = 0.076.

Article Snippet: Serum was analyzed at the University of Missouri Diabetes Diagnostic Laboratory for hemoglobin A1c (HbA1c) (using the Tosoh G8 variant mode ion-exchange HPLC method; Tosoh Biosciences, San Francisco, CA).

Techniques: Control, Labeling

Comparison between TOSOH G8 in  variant HbA1c mode,  Minicap FP system, and sickle solubility test

Journal: Journal of Clinical Laboratory Analysis

Article Title: Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange

doi: 10.1002/jcla.22453

Figure Lengend Snippet: Comparison between TOSOH G8 in variant HbA1c mode, Minicap FP system, and sickle solubility test

Article Snippet: Conclusion Hemoglobin S results obtained with TOSOH G8 in variant HbA1c mode are clinically acceptable to monitor urgent RCE.

Techniques: Comparison, Variant Assay, Solubility, Sample Prep, Software

Passing‐Bablok regression analysis comparing hemoglobin S (HbS) results (A) and hemoglobin F (HbF) results (B) obtained with TOSOH G8 in variant HbA1c mode and Minicap Flex Piercing (FP) system

Journal: Journal of Clinical Laboratory Analysis

Article Title: Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange

doi: 10.1002/jcla.22453

Figure Lengend Snippet: Passing‐Bablok regression analysis comparing hemoglobin S (HbS) results (A) and hemoglobin F (HbF) results (B) obtained with TOSOH G8 in variant HbA1c mode and Minicap Flex Piercing (FP) system

Article Snippet: Conclusion Hemoglobin S results obtained with TOSOH G8 in variant HbA1c mode are clinically acceptable to monitor urgent RCE.

Techniques: Variant Assay

Bland‐Altman plot comparing hemoglobin S (HbS) results (A) and hemoglobin F (HbF) results (B) obtained with TOSOH G8 in variant HbA1c mode and Minicap Flex Piercing (FP) system

Journal: Journal of Clinical Laboratory Analysis

Article Title: Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange

doi: 10.1002/jcla.22453

Figure Lengend Snippet: Bland‐Altman plot comparing hemoglobin S (HbS) results (A) and hemoglobin F (HbF) results (B) obtained with TOSOH G8 in variant HbA1c mode and Minicap Flex Piercing (FP) system

Article Snippet: Conclusion Hemoglobin S results obtained with TOSOH G8 in variant HbA1c mode are clinically acceptable to monitor urgent RCE.

Techniques: Variant Assay

Chromatogram with TOSOH G8 in variant HbA1c mode and Minicap Flex Piercing (FP) system. TOSOH G8 in variant HbA1c mode: hemoglobin S (HbS) is reported as H‐V1. Minicap FP system: Hemoglobin F (HbF), HbS and hemoglobin A2 (HbA2) peak identification is done by an experienced laboratory technician

Journal: Journal of Clinical Laboratory Analysis

Article Title: Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange

doi: 10.1002/jcla.22453

Figure Lengend Snippet: Chromatogram with TOSOH G8 in variant HbA1c mode and Minicap Flex Piercing (FP) system. TOSOH G8 in variant HbA1c mode: hemoglobin S (HbS) is reported as H‐V1. Minicap FP system: Hemoglobin F (HbF), HbS and hemoglobin A2 (HbA2) peak identification is done by an experienced laboratory technician

Article Snippet: Conclusion Hemoglobin S results obtained with TOSOH G8 in variant HbA1c mode are clinically acceptable to monitor urgent RCE.

Techniques: Variant Assay

Analytical imprecision of HbS analysis on TOSOH G8 in  variant HbA1c mode

Journal: Journal of Clinical Laboratory Analysis

Article Title: Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange

doi: 10.1002/jcla.22453

Figure Lengend Snippet: Analytical imprecision of HbS analysis on TOSOH G8 in variant HbA1c mode

Article Snippet: Conclusion Hemoglobin S results obtained with TOSOH G8 in variant HbA1c mode are clinically acceptable to monitor urgent RCE.

Techniques: Variant Assay

HbF and HbS results from the comparison study between TOSOH G8 in  variant HbA1c mode  and Minicap FP system

Journal: Journal of Clinical Laboratory Analysis

Article Title: Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange

doi: 10.1002/jcla.22453

Figure Lengend Snippet: HbF and HbS results from the comparison study between TOSOH G8 in variant HbA1c mode and Minicap FP system

Article Snippet: Conclusion Hemoglobin S results obtained with TOSOH G8 in variant HbA1c mode are clinically acceptable to monitor urgent RCE.

Techniques: Comparison, Variant Assay